Arrowhead Pharmaceuticals, Inc. (ARWR)
82.85
+0.09
(+0.11%)
USD |
NASDAQ |
Sep 11, 16:00
82.79
-0.06
(-0.07%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Price to Book Value : 25.12 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 25.12 |
| September 10, 2026 | 25.09 |
| September 09, 2026 | 25.05 |
| September 08, 2026 | 25.80 |
| September 04, 2026 | 26.18 |
| September 03, 2026 | 26.22 |
| September 02, 2026 | 25.88 |
| September 01, 2026 | 25.08 |
| August 31, 2026 | 24.98 |
| August 28, 2026 | 25.74 |
| August 27, 2026 | 26.86 |
| August 26, 2026 | 27.02 |
| August 25, 2026 | 26.95 |
| August 24, 2026 | 26.29 |
| August 21, 2026 | 26.41 |
| August 20, 2026 | 26.52 |
| August 19, 2026 | 27.11 |
| August 18, 2026 | 26.65 |
| August 17, 2026 | 26.89 |
| August 14, 2026 | 26.27 |
| August 13, 2026 | 25.95 |
| August 12, 2026 | 26.45 |
| August 11, 2026 | 27.06 |
| August 10, 2026 | 26.78 |
| August 07, 2026 | 26.57 |
| Date | Value |
|---|---|
| August 06, 2026 | 26.02 |
| August 05, 2026 | 26.35 |
| August 04, 2026 | 27.16 |
| August 03, 2026 | 26.08 |
| July 31, 2026 | 25.66 |
| July 30, 2026 | 26.47 |
| July 29, 2026 | 26.14 |
| July 28, 2026 | 26.01 |
| July 27, 2026 | 25.93 |
| July 24, 2026 | 25.95 |
| July 23, 2026 | 26.31 |
| July 22, 2026 | 26.89 |
| July 21, 2026 | 22.59 |
| July 20, 2026 | 21.72 |
| July 17, 2026 | 22.53 |
| July 16, 2026 | 21.64 |
| July 15, 2026 | 21.77 |
| July 14, 2026 | 21.80 |
| July 13, 2026 | 22.47 |
| July 10, 2026 | 23.16 |
| July 09, 2026 | 25.47 |
| July 08, 2026 | 25.99 |
| July 07, 2026 | 26.37 |
| July 06, 2026 | 26.24 |
| July 02, 2026 | 25.46 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics, Inc. | 1.414 |
| Revolution Medicines, Inc. | 16.75 |
| Moderna, Inc. | 8.496 |
| Intellia Therapeutics, Inc. | 2.259 |
| Denali Therapeutics, Inc. | 4.034 |
Price to Book Value Related Metrics
| PS Ratio | 17.39 |
| PEG Ratio | -0.4763 |
| Price | 82.85 |
| Earnings Yield | -2.71% |
| Market Cap | 11.69B |
| PEGY Ratio | -0.4763 |